{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:50:43Z","timestamp":1782247843906,"version":"3.54.5"},"reference-count":76,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Mycosis fungoides (MF) and S\u00e9zary syndrome (SS) are the most common types of primary cutaneous T-cell lymphoma (CTCL). Proliferating cell nuclear antigen (PCNA) is expressed on the cell surface of cancer cells (csPCNA), but not on normal cells. It functions as an immune checkpoint ligand by interacting with natural killer (NK) cells through the NK inhibitory receptor NKp44, leading to the inhibition of NK cytotoxicity. A monoclonal antibody (mAb14) was established to detect csPCNA on cancer cells and block their interaction with NKp44. In this study, three CTCL cell lines and peripheral blood mononuclear cells (PBMCs) from patients with SS and healthy donors were analyzed for csPCNA using mAb14, compared to monoclonal antibody PC10, against nuclear PCNA (nPCNA). The following assays were used: immunostaining, imaging flow cytometry, flow cytometry, cell sorting, cell cycle analysis, ELISA, and the NK-cell cytotoxic assay. mAb14 successfully detected PCNA on the membrane and in the cytoplasm of viable CTCL cell lines associated with the G2\/M phase. In the S\u00e9zary PBMCs, csPCNA was expressed on lymphoma cells that had an atypical morphology and not on normal cells. Furthermore, it was not expressed on PBMCs from healthy donors. In the co-culture of peripheral blood NK (pNK) cells with CTCL lines, mAb14 increased the secretion of IFN-\u03b3, indicating the reactivation of pNK activity. However, mAb14 did not enhance the cytotoxic activity of pNK cells against CTCL cell lines. The unique expression of csPCNA detected by mAb14 suggests that csPCNA and mAb14 may serve as a potential biomarker and tool, respectively, for detecting malignant cells in SS and possibly other CTCL variants.<\/jats:p>","DOI":"10.3390\/cancers15174421","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:24:30Z","timestamp":1693823070000},"page":"4421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy"],"prefix":"10.3390","volume":"15","author":[{"given":"Jamal","family":"Knaneh","sequence":"first","affiliation":[{"name":"Laboratory for Molecular Dermatology, Felsenstein Medical Research Center, Tel Aviv 6997801, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmilia","family":"Hodak","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Dermatology, Felsenstein Medical Research Center, Tel Aviv 6997801, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Davidoff Cancer Center, Rabin Medical Center, Petach Tikva 4941492, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6025-7359","authenticated-orcid":false,"given":"Shlomit","family":"Fedida-Metula","sequence":"additional","affiliation":[{"name":"PiNK Biopharma Ltd., Ness Ziona 7403648, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9232-6635","authenticated-orcid":false,"given":"Avishay","family":"Edri","sequence":"additional","affiliation":[{"name":"The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Eren","sequence":"additional","affiliation":[{"name":"PiNK Biopharma Ltd., Ness Ziona 7403648, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Yoffe","sequence":"additional","affiliation":[{"name":"PiNK Biopharma Ltd., Ness Ziona 7403648, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Amitay-Laish","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 4941492, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Prag Naveh","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Division of Dermatology, Rabin Medical Center, Petach Tikva 4941492, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Lubin","sequence":"additional","affiliation":[{"name":"Core Facility, Felsenstein Medical Research Center, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Porgador","sequence":"additional","affiliation":[{"name":"The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410101, Israel"},{"name":"National Institute for Biotechnology in the Negev, Ben Gurion University of the Negev, Beer Sheva 8410101, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach","family":"Moyal","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Dermatology, Felsenstein Medical Research Center, Tel Aviv 6997801, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel"},{"name":"Davidoff Cancer Center, Rabin Medical Center, Petach Tikva 4941492, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: A biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"290685","DOI":"10.1155\/2012\/290685","article-title":"Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors","volume":"2012","author":"Rodd","year":"2012","journal-title":"Lymphoma"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/jclinpath-2015-203133","article-title":"Primary cutaneous T-cell lymphomas: A review","volume":"68","author":"Sidiropoulos","year":"2015","journal-title":"J. Clin. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/ajd.12349","article-title":"Mycosis fungoides and S\u00e9zary syndrome: Current challenges in assessment, management and prognostic markers","volume":"57","author":"Hughes","year":"2016","journal-title":"Australas. J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1002\/art.21395","article-title":"Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis","volume":"52","author":"Chan","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cyto.b.20395","article-title":"CD158k\/KIR3DL2 is a useful marker for identifying neoplastic T-cells in S\u00e9zary syndrome by flow cytometry","volume":"74","author":"Bahler","year":"2008","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.jid.5701013","article-title":"CD158K\/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sezary syn-drome","volume":"128","author":"Ortonne","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.1251","article-title":"Killer cell immunoglobu-lin-like receptor expression delineates in situ Sezary syndrome lymphocytes","volume":"199","author":"Wechsler","year":"2003","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0625.2012.01489.x","article-title":"CD158k\/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides","volume":"21","author":"Ortonne","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V97.5.1388","article-title":"CD4+ cutaneous T-cell lymphoma cells express the p140\u2013killer cell immunoglobulin-like receptor","volume":"97","author":"Bagot","year":"2001","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: Relevance for the diagnosis and follow-up of Sezary syndrome","volume":"122","author":"Schiavon","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood-2017-06-792382","article-title":"KIR3DL2 expression in cutaneous T-cell lymphomas: Expanding the spectrum for KIR3DL2 targeting","volume":"130","author":"Battistella","year":"2017","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/1078-0432.CCR-16-3185","article-title":"Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with S\u00e9zary Syndrome","volume":"23","author":"Hurabielle","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fonc.2018.00198","article-title":"New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma","volume":"8","author":"Fujii","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/mabs.20230","article-title":"Brentuximab vedotin","volume":"4","author":"Dhimolea","year":"2012","journal-title":"mAbs"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-065X.2011.01057.x","article-title":"OX40 and CD30 signals in CD4+ T-cell effector and memory function: A distinct role for lymphoid tissue inducer cells in maintaining CD4+ T-cell memory but not effector function","volume":"244","author":"Withers","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0019-5154.77563","article-title":"Extrinsic apoptotic pathways: A new potential \u201ctarget\u201d for more sufficient therapy in a case of cutaneous anaplastic large cd30+ alk-T-cell lymphoma","volume":"56","author":"Tchernev","year":"2021","journal-title":"Indian J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2133.2007.08008.x","article-title":"Transformed mycosis fungoides: Clinicopathological features and outcome","volume":"157","author":"Barberio","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/PAT.0000000000000166","article-title":"Mycosis fungoides with large cell transformation: Clinicopathological features and prognostic factors","volume":"46","author":"Pulitzer","year":"2014","journal-title":"Pathology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","article-title":"CD30 expression and proliferative fraction in nontransformed mycosis fungoides","volume":"33","author":"Edinger","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2011","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1182\/blood-2012-10-460535","article-title":"Use of PLS3, Twist, CD158k\/KIR3DL2, and NKp46 gene expression combination for reliable S\u00e9zary syndrome diagnosis","volume":"121","author":"Michel","year":"2013","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20071944","article-title":"Development of all CD4 T lineages requires nuclear factor TOX","volume":"205","author":"Aliahmad","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.18632\/oncotarget.5742","article-title":"Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma","volume":"10","author":"Dulmage","year":"2019","journal-title":"Oncotarget"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.18632\/oncotarget.2031","article-title":"Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis","volume":"5","author":"Huang","year":"2014","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00403-014-1501-7","article-title":"TOX expression in different subtypes of cutaneous lymphoma","volume":"306","author":"Morimura","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.leu.2405044","article-title":"S\u00e9zary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3","volume":"22","author":"Booken","year":"2008","journal-title":"Leukemia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"31868","DOI":"10.18632\/oncotarget.5573","article-title":"EPHA4 is overexpressed but not functionally active in S\u00e9zary syndrome","volume":"6","author":"Hameetman","year":"2015","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jid.2013.279","article-title":"CD164 and FCRL3 are highly expressed on CD4+CD26-T cells in S\u00e9zary syndrome patients","volume":"134","author":"Wysocka","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u03b2 chain restriction","volume":"74","author":"Gibson","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41563-019-0567-1","article-title":"Syndecan-4 tunes cell mechanics by activating the kindlin-integrin-RhoA pathway","volume":"19","author":"Chronopoulos","year":"2020","journal-title":"Nat. Mater."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2010-08-302034","article-title":"S\u00e9zary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-\u03b2 on the cell surface","volume":"117","author":"Chung","year":"2011","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"714298","DOI":"10.3389\/fcell.2021.714298","article-title":"Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaad.2018.06.025","article-title":"CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases","volume":"79","author":"Yuki","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1346-8138.15078","article-title":"The expression of cell adhesion molecule 1 and its splicing variants in S\u00e9zary cells and cell lines from cutaneous T-cell lymphoma","volume":"46","author":"Yamaguchi","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B Cell\u2013attracting Chemokine 1, a Human CXC Chemokine Expressed in Lymphoid Tissues, Selectively Attracts B Lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjd.21791","article-title":"Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: An integrative clinical, pathological and molecular case series study","volume":"187","author":"Wang","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-08-0602","article-title":"CXCL13 is highly produced by Sezary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines","volume":"68","author":"Picchio","year":"2008","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/DAD.0000000000000258","article-title":"Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-Cell Lymphomas","volume":"37","author":"Bosisio","year":"2015","journal-title":"Am. J. Dermatopathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cu-taneous lymphoma: Recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.1102267","article-title":"Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44","volume":"187","author":"Rosental","year":"2011","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0092-8674(94)90014-0","article-title":"Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA","volume":"79","author":"Krishna","year":"1994","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0167-5699(00)01596-6","article-title":"Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis","volume":"21","author":"Moretta","year":"2000","journal-title":"Immunol. Today"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.it.2013.01.003","article-title":"Activating natural cytotoxicity receptors of natural killer cells in cancer and infection","volume":"34","author":"Koch","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/icb.2013.98","article-title":"Natural cytotoxicity receptors and their ligands","volume":"92","author":"Kruse","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non\u2013major histocompatibility complex\u2013restricted Tumor Cell Lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1021\/bi7000455","article-title":"Characterization of the Recognition of Tumor Cells by the Natural Cytotoxicity Receptor, NKp44","volume":"46","author":"Hershkovitz","year":"2007","journal-title":"Biochemistry"},{"key":"ref_50","first-page":"1545","article-title":"Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA","volume":"138","author":"Wood","year":"1991","journal-title":"Am. J. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.0022-202X.2005.23914.x","article-title":"Circulating Natural Killer Lymphocytes Are Potential Cytotoxic Effectors Against Autologous Malignant Cells in Sezary Syndrome Patients","volume":"125","author":"Bouaziz","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.4049\/jimmunol.130.5.2467","article-title":"Sezary syndrome. I. Specific skin-directed migration of peripheral blood lymphocytes","volume":"130","author":"Laroche","year":"1983","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/2326-6066.CIR-19-0023","article-title":"Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA","volume":"7","author":"Kundu","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2559.1991.tb00890.x","article-title":"The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S G2 M phase fraction (flow cytometric analysis) and prognosis","volume":"19","author":"Woods","year":"1991","journal-title":"Histopathology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/OTT.S126551","article-title":"Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expressionin gastric cancer: A systematic review and meta-analysis","volume":"10","author":"Yin","year":"2017","journal-title":"OncoTargets Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1016\/j.febslet.2010.09.021","article-title":"Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer","volume":"584","author":"Naryzhny","year":"2010","journal-title":"FEBS Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/onci.19366","article-title":"A novel mechanism for cancer cells to evade immune attack by NK cells","volume":"1","author":"Rosental","year":"2012","journal-title":"OncoImmunology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.20030630","article-title":"Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function","volume":"198","author":"Stetson","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_59","first-page":"899","article-title":"NKp44 Triggers NK Cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence","volume":"172","author":"Campbell","year":"2004","journal-title":"Perspect. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1083\/jcb.150.5.1113","article-title":"Annexins in cell membrane dynamics. Ca2+-regulated association of lipid microdomains","volume":"150","author":"Babiychuk","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s11033-011-0859-2","article-title":"Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas","volume":"39","author":"Feng","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/mc.22145","article-title":"Under-expression of annexin A2 is associated with Kazakh\u2019s esophageal squamous cell carcinoma","volume":"54","author":"Li","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_63","first-page":"1082","article-title":"Blocking PCNA interaction with NKp44 enhances primary natural killer cell-mediated lysis of triple-negative breast cancer cells","volume":"13","author":"Marrufo","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/bjd.20519","article-title":"Mycosis fungoides-derived exosomes promote cell motility, are enriched with miR-155 and miR-1246, and their plasma cell-free expression may serve as potential biomarkers for disease burden","volume":"185","author":"Moyal","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjd.15422","article-title":"Oncogenic role of microRNA-155 in mycosis fungoides: An in vitro and xenograft mouse model study","volume":"177","author":"Moyal","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0303-6987.2006.00541.x","article-title":"On the diagnosis of erythrodermic cutaneous T-cell lymphoma","volume":"33","author":"Vonderheid","year":"2006","journal-title":"J. Cutan. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Harro, C.M., Sprenger, K.B., Chaurio, R.A., Powers, J.J., Innamarato, P., Anadon, C.M., Zhang, Y., Biswas, S., Mandal, G., and Mine, J.A. (2023). S\u00e9zary syndrome originates from heavily mutated hematopoietic progenitors. Blood Adv.","DOI":"10.1182\/bloodadvances.2022008562"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"33812","DOI":"10.1074\/jbc.M112.367839","article-title":"Nuclear-to-cytoplasmic relocalization of the proliferating cell nuclear antigen (PCNA) during differentiation involves a chromosome region maintenance 1 (CRM1)-dependent export and is a prerequisite for PCNA antiapoptotic activity in mature neutrophils","volume":"287","author":"Bouayad","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/1078-0432.CCR-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors","volume":"25","author":"Gaydosik","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-4632.2009.03771.x","article-title":"Overall survival in erythrodermic cutaneous T-cell lymphoma: An analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma","volume":"48","author":"Vidulich","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP1NA3YCHCDEIG","article-title":"Blood flow cy-tometry in Se\u2019zary syndrome: New insights on prognostic relevance and immunophenotypic changes during follow-up","volume":"143","author":"Novelli","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/10428190410001693560","article-title":"Cutaneous T-cell lymphoma: A paradigm for biological therapies","volume":"45","author":"Pichardo","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"95981","DOI":"10.18632\/oncotarget.21619","article-title":"Analysis of CTCL cell lines reveals important differences between mycosis fungoides\/S\u00e9zary sy drome vs. HTLV-1+ leukemic cell lines","volume":"8","author":"Netchiporouk","year":"2017","journal-title":"Oncotarget"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"92183","DOI":"10.18632\/oncotarget.21006","article-title":"Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with S\u00e9zary syndrome","volume":"8","author":"Manfrere","year":"2017","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Lorenzo-Herrero, S., Lopez-Soto, A., Sordo-Bahamonde, C., Gonzalez-Rodriguez, A.P., Vitale, M., and Gonzalez, S. (2019). NK cell-based im-munotherapy in cancer metastasis. Cancers, 11.","DOI":"10.3390\/cancers11010029"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Horton, N.C., Mathew, S.O., and Mathew, P.A. (2013). Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059552"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:46:25Z","timestamp":1760129185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/17\/4421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":76,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["cancers15174421"],"URL":"https:\/\/doi.org\/10.3390\/cancers15174421","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]}}}